CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
157 hedge funds and large institutions have $328M invested in Clovis Oncology, Inc. in 2020 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 59 increasing their positions, 38 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
3% more funds holding
Funds holding: 153 → 157 (+4)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
157
Holding in Top 10
1
Calls
$31.7M
Puts
$23.7M
Top Buyers
| 1 | +$37.6M | |
| 2 | +$12.4M | |
| 3 | +$12.1M | |
| 4 |
AC
Armistice Capital
New York
|
+$10.8M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$10.7M |
Top Sellers
| 1 | -$7.91M | |
| 2 | -$6.36M | |
| 3 | -$2.96M | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$2.69M |
| 5 |
SG Americas Securities
New York
|
-$2.68M |